Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our results provide evidence that deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
|
19177550 |
2009 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
We systematically analysed non-tumorous mucosa from carriers of a Lynch syndrome mutation (set 1: ten patients) and control patients without Lynch syndrome (set 1: nine patients) for MMR protein expression (MLH1, MSH2, and EPCAM) with immunohistochemistry.
|
22552011 |
2012 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Members of Family R and Family A, all with the same EPCAM deletion, predominantly presented with CRC but no LS-associated endometrial cancer, confirming findings seen in other, smaller, LS families with EPCAM mutations.
|
21769135 |
2011 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
|
23264089 |
2013 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
|
19455606 |
2009 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Lynch syndrome is the most common inherited CRC syndrome and is associated with mutations in DNA mismatch repair genes, mainly MLH1 and MSH2 but also MSH6, PMS2, and EPCAM.
|
23891921 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We found a novel large EPCAM-MSH2 duplication associated with LS and the presence of LOHs in regions containing numerous tumor suppressors, raising the hypothesis that these alterations could contribute to cancer susceptibility.
|
31655866 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Among confirmed LS, path_MLH1 variants were most commonly identified in Peru (82%), Mexico (80%), Chile (60%), and path_MSH2/EPCAM variants were most frequently identified in Colombia (80%) and Argentina (47%).
|
30303536 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
EPCAM-CL can be used to screen for EPCAM deletion-induced Lynch syndrome-associated CRC, whereas EPCAM-PL can be used as an indicator of tumor aggressiveness and poor prognosis in CRC.
|
26528695 |
2016 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
Biomarker
|
disease |
CTD_human |
Microsatellite instability: an update.
|
25701956 |
2015 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Members of Family R and Family A, all with the same EPCAM deletion, predominantly presented with CRC but no LS-associated endometrial cancer, confirming findings seen in other, smaller, LS families with EPCAM mutations.
|
21769135 |
2011 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.
|
23938213 |
2013 |